Type(s) of Cancer
Colorectal
Colorectal
Study Phase
Phase 3
Study Completion Date
October 2009
October 2009
NCT00305188Uploaded 04-28-2015
Available for Download
PDS UID: Colorec_SanofiU_2005_136
A Multicenter, Randomized Double-blind Placebo Controlled Phase III Study of the Efficacy of Xaliproden in Preventing the Neurotoxicity of Oxaliplatin in First-line Treatment of Patients With Metastatic Colorectal Cancer Treated With Oxaliplatin / 5-FU/LV
Files:
PROTOCOLsanofi_SR57746A_EFC5505_protocol_and_amendments_redacted.pdf
CRFsanofi_SR57746A_efc5505_crf_redacted.pdf
DATA DICTIONARYsanofi_SR57746A_EFC5505_data_definition.xls
DATA (COMPARATOR ARM)sanofi_sr57746A_efc5505_datasets_and readme.zip